Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: A meta-analysis

doi:10.3748/wjg.v21.i14.4365

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6209)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

386

WORD

203

HTML

2833

Figures (1-3)

182

Tables (1-2)

132

Sum=3736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1085

Download

1388

Sum=2473

Apr 14, 2015 (publication date) through Aug 3, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Apr 14, 2015; 21(14): 4365-4372
Published online Apr 14, 2015. doi: 10.3748/wjg.v21.i14.4365

Full Size Figure Download Figure

Figure 3 Subgroup analysis of progression-free survival based on chemotherapy regimen in KRAS wild-type patients following first-line treatment.

Citation: Song QB, Wang Q, Hu WG. Anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer: A meta-analysis. World J Gastroenterol 2015; 21(14): 4365-4372
URL: https://www.wjgnet.com/1007-9327/full/v21/i14/4365.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i14.4365